집중 치료실(ICU) 병상 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the intensive care unit (ICU) beds market size is expected to increase from USD 2.28 billion in 2025 to USD 2.45 billion in 2026 and reach USD 3.47 billion by 2031, growing at a CAGR of 7.25% over 2026-2031.

This report is Segmented by Product Type (Electric, Semi-Electric, Manual, Bariatric, Pediatric Beds), Application (General, Specialized, Pediatric and Neonatal, Cardiac ICUs, Other), End Use (Hospitals and Clinics, Ascs, Specialty Hospitals, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Intensive Care Unit (ICU) Beds Market Trends and Insights

Growing ICU Demand From Chronic Disease Burden

The ICU beds market is being pushed by a disease burden that is both large and persistent across major healthcare systems. A 2025 Journal of the American College of Cardiology analysis reported 626 million cardiovascular disease cases worldwide, and a 2025 Nature Medicine study reported 569.2 million chronic respiratory disease cases with 4.2 million deaths, which keeps a high baseline of patients flowing into high dependency and intensive care settings. The demand effect is stronger when cardiovascular and respiratory conditions overlap, because those patients often require longer ICU stays and more constant monitoring, which reduces functional capacity even when the physical bed count does not change. In England, the UK Office for Health Improvement and Disparities reported 873,461 emergency respiratory admissions in the financial year ending 2025, including more than 56,000 influenza admissions, which shows that pressure is still visible even in a well funded health system. WHO Europe also stated in 2025 that chronic respiratory disease remains a major long term burden in the region, which supports continued replacement and expansion demand in the ICU beds market. This keeps the ICU beds market tied to a structural care need rather than a short procurement cycle.

Hospital Digitization Is Pulling Demand Toward Smart ICU Beds

The ICU beds market is also moving toward beds that work as connected clinical platforms rather than as stand alone furniture. A 2025 Frontiers in Digital Health study showed that SmartICU frameworks combining real time data integration, predictive analytics, and workflow automation reduced average bed replacement intervals from 1.7 days to near real time in a Sao Paulo hospital pilot. The same study reported 56 minutes saved per patient per day through digitized nursing documentation, and it linked digital ICU models to prior studies that showed 12% lower mortality, which gives hospital buyers a clearer operational and clinical case for connected beds. Machine learning sepsis prediction models cited in that research achieved an AUROC of 0.952 and flagged onset up to 4 hours before clinical presentation, which strengthens the case for beds that can transmit continuous patient data into broader ICU systems. In practice, this means hospitals are screening out lower specification products at the tender stage when they lack sensor integration, connectivity pathways, or electronic medical record compatibility. That shift supports pricing strength in the ICU beds market because value is now tied more closely to interoperability and workflow support.

High Upfront Cost Limits Replacement Cycles in Budget-Constrained Hospitals

The ICU beds market still faces a clear funding barrier because full electric and connected ICU beds cost much more than manual or semi electric products. This cost gap matters most in hospitals that are trying to preserve capital while still managing high occupancy and staffing pressure. In those settings, buyers often delay replacement, split tenders across specification tiers, or reserve premium beds for new or renovated units rather than extending them across the full ICU fleet. That behavior slows the speed at which the ICU beds market can move toward higher value configurations even when clinical need is already present. It also creates a two track market in which premium suppliers compete for selective projects while lower specification products remain relevant in budget limited systems.

Other drivers and restraints analyzed in the detailed report include:

1. ICU Capacity Expansion in Emerging Care Networks
2. Shorter Bed Turnaround Time Through Infection-Control Design
3. Certification, Tender, and Reimbursement Friction Slows Adoption

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Electric beds held 39.31% of the ICU beds market share in 2025, which made them the default specification in acute care settings that need continuous repositioning, pressure injury prevention, and stronger caregiver support. Their role is supported by the way hospitals are standardizing around better ergonomics, broader patient monitoring integration, and higher safety expectations in critical care units. This part of the ICU beds market also benefits from the fact that electric systems fit more easily into digitized care environments, where workflow efficiency and patient handling are being treated as procurement priorities rather than as optional upgrades. Semi electric and manual beds still retained a role in cost sensitive markets, especially where public procurement budgets remain tight and the installed base is already large. That keeps the product mix broad, even though the center of gravity in the ICU beds market is still moving toward powered configurations.

The ICU beds market size for bariatric beds is projected to expand at 8.38% CAGR through 2031, making this the fastest growing product segment. Demand is rising because hospitals need beds that can safely manage higher weight loads while still providing articulation, positioning support, and staff safety in high acuity care. Manufacturers are responding with designs that combine high weight ratings, full electric movement, integrated lateral tilt, and onboard weighing capability, which lifts clinical utility beyond basic structural support. This matters because bariatric beds can also support pressure injury prevention and early mobilization for patients who may not be well served by standard ICU configurations. As a result, the ICU beds market is seeing a segment where premium pricing is easier to defend because the clinical and operational value is more specific.

Complete Report Scope:

• By Product Type
  • Electric Beds
  • Semi-Electric Beds
  • Manual Beds
  • Bariatric Beds
  • Pediatric Beds
• By Application
  • General ICUs
  • Specialized ICUs
  • Pediatric and Neonatal ICUs
  • Cardiac ICUs
  • Other Applications
• By End Use
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Specialty Hospitals
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 35.22% of the ICU beds market in 2025, which made it the largest regional segment. The region benefits from a deep installed ICU base, active replacement cycles, and the financial ability to move earlier toward connected and higher specification products. Mount Sinai Health System is building a new 21-bed ICU at Mount Sinai Queens, which will nearly triple the hospital's critical care capacity and shows that capacity expansion remains active in a major urban market in 2026. Northwestern Memorial Hospital is also pursuing a 42-bed ICU expansion tied to emergency department backlogs, which points to a direct connection between hospital flow pressure and critical care investment. Europe remained the second largest regional cluster, where mature hospital systems and tighter device standards support demand for more advanced products even when procurement timing is uneven.

Asia-Pacific is projected to expand at 9.65% CAGR through 2031, giving it the fastest regional growth in the ICU beds market. This pace reflects government led healthcare expansion, rising chronic disease prevalence, and stronger private hospital investment across China, India, and Southeast Asia. India's broad hospital network under AB-PMJAY and continued critical care buildout support volume growth, while Stryker's June 2025 launch of the APAISER X1 for the Indian market shows that global suppliers are localizing products for this opportunity. Japan also remains important in the ICU beds market, where Paramount Bed introduced an Arius ICU bed with powered transport assistance in June 2025 to address nursing workload and mobility needs. These examples show that Asia-Pacific growth is not only about adding units, it is also about moving toward more specialized and better integrated products.

The Middle East and Africa region is growing steadily in the ICU beds market, supported by healthcare infrastructure programs in the Gulf and by private hospital investment in key urban centers. Demand in this region is often strongest for specialty ICU and bariatric configurations where hospitals are trying to align capacity with premium care offerings and medical tourism strategies. South Africa remains an anchor for sub-Saharan procurement because private hospital groups typically move faster on capital projects than many public systems. South America continues to offer a meaningful installed base, especially in Brazil, but procurement timing is often shaped by public tender cycles and reimbursement fragmentation, which keeps growth below the pace seen in Asia-Pacific. This leaves the ICU beds market with a regional profile in which North America leads on current scale, Asia-Pacific leads on growth, and the rest of the world adds selective but still important demand pockets.

1. Arjo AB
2. Baxter
3. Favero Health Projects S.p.A.
4. Gendron
5. Getinge
6. Invacare
7. LINET Group
8. Malvestio S.p.A.
9. Medline Industries
10. Merivaara
11. MESPA
12. Nitrocare Medical Bed
13. Paramount Bed Co., Ltd.
14. Savion Industries Ltd.
15. Stiegelmeyer GmbH and Co. KG
16. Stryker
17. Umano Medical Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing ICU Demand From Chronic Disease Burden
  • 4.2.2 Hospital Digitization Is Pulling Demand Toward Smart ICU Beds
  • 4.2.3 ICU Capacity Expansion in Emerging Care Networks
  • 4.2.4 Shorter Bed Turnaround Time Through Infection-Control Design
  • 4.2.5 Rising Focus on Staff Ergonomics and Safe Patient Handling
  • 4.2.6 Procurement Shift Toward Modular Beds With Upgradeable Interfaces
• 4.3 Market Restraints
  • 4.3.1 High Upfront Cost Limits Replacement Cycles in Budget-Constrained Hospitals
  • 4.3.2 Certification, Tender, and Reimbursement Friction Slows Adoption
  • 4.3.3 Biomedical Maintenance and Spare-Part Dependence Raises Total Cost of Ownership
  • 4.3.4 ICU Space Constraints Reduce Retrofit Feasibility in Legacy Facilities
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Electric Beds
  • 5.1.2 Semi-Electric Beds
  • 5.1.3 Manual Beds
  • 5.1.4 Bariatric Beds
  • 5.1.5 Pediatric Beds
• 5.2 By Application
  • 5.2.1 General ICUs
  • 5.2.2 Specialized ICUs
  • 5.2.3 Pediatric and Neonatal ICUs
  • 5.2.4 Cardiac ICUs
  • 5.2.5 Other Applications
• 5.3 By End Use
  • 5.3.1 Hospitals and Clinics
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Specialty Hospitals
  • 5.3.4 Others
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Arjo AB
  • 6.3.2 Baxter International Inc.
  • 6.3.3 Favero Health Projects S.p.A.
  • 6.3.4 Gendron Inc.
  • 6.3.5 Getinge AB
  • 6.3.6 Invacare Corporation
  • 6.3.7 LINET Group SE
  • 6.3.8 Malvestio S.p.A.
  • 6.3.9 Medline Industries, Inc.
  • 6.3.10 Merivaara Corp.
  • 6.3.11 MESPA
  • 6.3.12 Nitrocare Medical Bed
  • 6.3.13 Paramount Bed Co., Ltd.
  • 6.3.14 Savion Industries Ltd.
  • 6.3.15 Stiegelmeyer GmbH and Co. KG
  • 6.3.16 Stryker Corporation
  • 6.3.17 Umano Medical Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & unmet-need assessment